Benitec Biopharma Limited Revenue per Share

Revenue per Share of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue per Share growth rates and interactive chart. Calculated as total revenue divided by the number of weighted average shares outstanding in the period. It can be easily compared to the stock price to determine how revenue is an investor getting for every $1 paid for a stock.


Highlights and Quick Summary

  • Revenue per Share for the quarter ending September 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Revenue per Share decreased by -100.0%
  • Annual Revenue per Share for 2022 was 1.78 (a 50894.29% increase from previous year)
  • Annual Revenue per Share for 2022 was 0.0 (a -99.87% decrease from previous year)
  • Annual Revenue per Share for 2021 was 2.74 (a 51677.36% increase from previous year)
  • Twelve month Revenue per Share ending September 30, 2022 was 0.0 (a -100.0% decrease compared to previous quarter)
  • Twelve month trailing Revenue per Share decreased by -100.0% year-over-year
Trailing Revenue per Share for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
0.0 0.0 0.0 0.0
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue per Share of Benitec Biopharma Limited

Most recent Revenue per Shareof BNTC including historical data for past 10 years.

Interactive Chart of Revenue per Share of Benitec Biopharma Limited

Benitec Biopharma Limited Revenue per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0 0.0 0.0 1.78
2021 0.0 0.0 0.09 0.04 2.74
2020 0.05 9.17 -7.06 5.19 20.0
2019 0.0 7.67 2836.98
2018 5.2
2017 1.19 14.3
2016 8.99 6.22
2015 8.64
2014 4.19
2013 0.43

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology